TITLE: Treating Hepatitis C in the Primary Care Setting: Establishing Clinical Readiness Through Mentored Learning

 

COMPONENT 1: Gather-ed Platform

 

CREDITS: Up to 4.25 AMA PRA Category 1 Credit(s)™ or 4.25 AANP Contact Hours (which includes 0.25 hour(s) of pharmacology)

 

LAUNCH DATE: October 29, 2021

EXPIRATION DATE: November 28, 2022

 

PRIMARY AUDIENCE: Primary care physicians, NPs, PAs, and other clinicians involved in the care of patients with or at risk of HCV infection

 

RELEVANT TERMS: HCV, hepatitis C, hepatitis C virus, HCV infection, hep C, primary care, PCP

 

COURSE FACULTY

Stacey B. Trooskin, MD, PhD, MPH
Chief Medical Officer
Philadelphia FIGHT
Clinical Assistant Professor of Medicine
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

 

LEARNING OBJECTIVES

Upon completion of this activity, the participant should be better able to:

• Demonstrate a comprehensive understanding of the HCV care continuum
• Apply Centers for Disease Control and Prevention (CDC) guidelines for HCV universal screening and risk-based testing
• Utilize AASLD/IDSA simplified HCV treatment guidelines
• Provide patient education, counseling, and support across the HCV care continuum
• Promote harm-reduction principles and practices

 

COURSE SUMMARY

This online, interactive curriculum will provide continuing education (CME/CE) for primary care providers (PCPs) to support their competence and confidence in treating patients with chronic hepatitis C virus (HCV) infection. Small-group workshops will utilize novel collaborative-education methodologies, facilitate peer-to-peer learning, and promote sharing of strategies for overcoming challenges inherent to adoption of new clinical practices.

 

PLANNING COMMITTEE

Michelle Frisch, MPH
Vice President, Operations
National Association for Continuing Education
Plantation, FL

 

Angela Golden, DNP, FNP-C, FAANP
NP Obesity Treatment Clinic
NP from Home, LLC
Assistant Professor (Ret), Northern Arizona University
Past President, American Association of Nurse Practitioners
Munds Park, AZ

 

Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL

 

Jeanette Ruby, MD
Vice President, Scientific Services
Integritas Communications Group
Hoboken, NJ

 

Jim Kappler, PhD
Integritas Communications Group
Hoboken, NJ

 

Becky Carney, MSPT
Senior VP, Educational Strategy
Integritas Communications Group
Hoboken, NJ

 

Christa Master
Vice President, Account Services
Integritas Communications Group
Hoboken, NJ

 

ACCREDITATION INFORMATION

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and Integritas Communications. NACE is accredited by the ACCME to provide continuing medical education for physicians.

NACE designates this other (blended live and enduring curriculum) activity for a maximum of 4.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and Integritas Communications.  The NACE is accredited by AANP as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for a maximum of 4.25 contact hours (which includes 0.25 hour(s) of pharmacology).

 

DISCLOSURE POLICY

Accredited education provided by the National Association for Continuing Education (NACE) must demonstrate balance, independence, objectivity, and scientific rigor. All individuals in a position to influence content of NACE accredited education are required to disclose all financial relationships with ineligible companies within the previous 24-month period, regardless of relevance to the education. All relevant financial relationships and potential conflicts of interest will be mitigated prior to the activity.

NACE defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

 

INDIVIDUAL DISCLOSURES

Course Faculty

Stacey B. Trooskin, MD, PhD, MPH: Advisory Board Member: Gilead Sciences Contracted Research: Gilead Sciences

Dr. Trooskin’s relevant financial relationships have been mitigated.

 

Group Leaders

Gregory “Grey” Felzien, MD, AAHIVS: No financial relationships to disclose

David Wyles, MD: Contracted Research: Gilead Sciences, Inc.

Sherilyn Brinkley, NP: Advisor: AbbVie; Speaker: AbbVie, Gilead Sciences, Inc.

 

Planning Committee

Michelle Frisch, MPH, CHCP: No financial relationships to disclose

Angela Golden, DNP, FNP-C, FAANP: No financial relationships to disclose

Gregg Sherman, MD: No financial relationships to disclose

Jeanette Ruby, MD: No financial relationships to disclose

Jim Kappler, PhD: No financial relationships to disclose

Becky Carney, MSPT: No financial relationships to disclose

Christa Master: No financial relationships to disclose

 

STATEMENT OF COMMERCIAL SUPPORT

This activity is supported by an independent educational grant from Gilead Sciences, Inc.

 

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

 

How to claim credit

1. Review the course front matter.
2. Participate in the course.
3. Once your group completes all modules of the course, you will receive a notification with a link to complete the posttest, activity evaluation and claim your CE credit.
4. You must score 75% or higher on the posttest to claim credit for this activity.
5. Claim total credit commensurate with your participation in the activity as follows:

 

• Treating Hepatitis C in the Primary Care Setting - Self Study: Baseline Assessment

• 0.5 AMA PRA Category 1 Credits™
• 0.5 AANP contact hour(s)

• Self-Study Module 1: Introduction to HCV Testing and Treatment Guidelines

• 0.5 AMA PRA Category 1 Credits™
• 0.5 AANP contact hour(s) (which includes 0.25 hour(s) of pharmacology)

• Self-Study Module 2: HCV Case Study - Jackie

• 0.25 AMA PRA Category 1 Credits™
• 0.25 AANP contact hour(s)

• Self-Study Module 3: HCV Case Study - Ronald

• 0.25 AMA PRA Category 1 Credits™
• 0.25 AANP contact hour(s)

• Self-Study Module 4: HCV Case Study - Glenda

• 0.25 AMA PRA Category 1 Credits™
• 0.25 AANP contact hour(s)

• Live Group Discussion 1: Get Ready to Treat HCV in Your Primary Care Practice

• 0.5 AMA PRA Category 1 Credits™
• 0.5 AANP contact hour(s)

• Live Group Discussion 2: Hands-on HCV Care — A Step-by-Step Application of the AASLD/IDSA Simplified HCV Treatment Guidelines

• 0.5 AMA PRA Category 1 Credits™
• 0.5 AANP contact hour(s)

• Live Group Discussion 3: Overcoming Challenges Along the HCV Care Continuum — Strategies, Tactics, and Tools

• 0.5 AMA PRA Category 1 Credits™
• 0.5 AANP contact hour(s)

• Group Task: The Path to HCV Cure

• 0.5 AMA PRA Category 1 Credits™
• 0.5 AANP contact hour(s)

• Treating Hepatitis C in the Primary Care Setting - Self Study: Final Assessment

• 0.5 AMA PRA Category 1 Credits™
• 0.5 AANP contact hour(s)

 

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.